MetaCap

Boundless Bio (BOLD) vs RenovoRx (RNXT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Boundless Bio (BOLD) has outperformed RenovoRx (RNXT) over the past year, gaining 114.6% versus a gain of 12.3%. RenovoRx is the larger company by market cap ($60.0 million vs $58.7 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BOLD+114.63%RNXT+12.30%
+153%+52%-49%
Oct 7, 20251 yearOct 7, 2026
BOLD-81.47%RNXT+2.24%
+87%-7%-101%
Mar 25, 20245 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BOLD versus RNXT key metrics
MetricBOLDRNXT
Share price$2.58$1.33
Market cap$58.69M$60.02M
1-day change-2.27%-2.92%
YTD return+120.00%+63.10%
1-year return+114.63%+12.30%
5-year return—-77.09%
EPS (TTM)$-2.85$-0.31
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$3.16$2.59
52-week low$0.961$0.701
Distance from 52-week high-18.46%-48.65%
Average volume179.14K761.09K
Shares outstanding22.75M45.13M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BOLD has outperformed RNXT by 102.3 percentage points over the past year.

BOLD vs RNXT FAQ

Which is bigger, Boundless Bio or RenovoRx?

RenovoRx (RNXT) is larger, with a market capitalization of $60.02M compared with $58.69M for Boundless Bio (BOLD).

Which stock has performed better over the past year, BOLD or RNXT?

BOLD returned +114.63% over the past 12 months, compared with +12.30% for RNXT (price return, excluding dividends). Past performance does not predict future results.

Are Boundless Bio and RenovoRx in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons